Abstract
Background Adiponectin and apolipoprotein M (apoM) are adipokines indicatives of healthy adipose tissue and down-regulated with obesity. We compared circulating apoM with adiponectin regarding their relationship with metabolic parameters and insulin sensitivity and examined their gene expression patterns in adipocytes and in the adipose tissue.
Methods Circulating apoM and adiponectin were examined in 169 men with overweight in a cross-sectional study, and 13 patients with obesity during a surgery-induced slimming program. Correlations with clinical parameters including the insulin resistance index (HOMA-IR) were analyzed. Multiple regression analyses were performed on HOMA-IR. The APOM and ADIPOQ gene expression were measured in the adipose tissue from 267 individuals with obesity and a human adipocyte cell line.
Results Participants with type 2 diabetes had lower circulating adiponectin and apoM, while apoM was higher in individuals with dyslipidemia. Similar to adiponectin, apoM showed negative associations with HOMA-IR and hs-CRP (r>-0.2), and positive correlations with HDL markers (HDL-C and apoA-I, r>0.3). Unlike adiponectin, apoM was positively associated with LDL markers (LDL-C and apoB100, r< 0.20) and negatively correlated with insulin and age (r>-0.2). The apoM was the sole negative determinant of HOMA-IR in multiple regression models, while adiponectin not contributing significantly. After surgery, the change in HOMA-IR was negatively associated with the change in circulating apoM (r=-0.71), but not with the change in adiponectin. The APOM and ADIPOQ gene expression positively correlated in adipose tissue (r>0.44) as well as in adipocytes (r>0.81). In adipocytes, APOM was downregulated by inflammatory factors and upregulated by adiponectin.
Conclusions The apoM rises as a new partner of adiponectin regarding insulin sensitivity. At the adipose tissue level, the adiponectin may be supported by apoM to promote a healthy adipose tissue.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Region Occitanie Pyrenees-Mediterranee (GRAINE HEPATOCARE, Reference number 19014226), Inserm, Toulouse 3 University, and grants from Societe Francaise de Nutrition.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocols were approved by the local ethics committee: Comite de protection des personnes, Toulouse/Sud-Ouest, file #1-99-48, Feb 2000; and the the Research Ethics Board of Aix-Marseille University (NCT01277068, registered 13 January 2011; NCT02332434, registered 5 January 2015; and NCT00390637, registered 20 October 2006).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Competing interests The authors have no conflicts of interest to declare.
We have added APOM and ADIPOQ gene expression data in human adipose tissue and regulation of APOM and ADIPOQ gene expression in hMADS adipocytes.
Data Availability
The datasets analyzed during the current study are not publicly available but are available from the corresponding authors on reasonable request.
